← Browse by Condition
Medical Condition

perimenopause

Total Trials
4
Recruiting Now
4
Trial Phases
Various

ClinicalMetric tracks all active clinical trials for perimenopause sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — perimenopause Clinical Trials

How many clinical trials are currently recruiting for perimenopause?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for perimenopause, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for perimenopause?
perimenopause research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a perimenopause clinical trial?
Eligibility criteria for perimenopause trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
Northumbria University 2 trials
Chronic Conditions Research Fund 1 trial
King's College London 1 trial

Recruiting Clinical Trials

NCT07235878
Recruiting
12-week Magnesium Supplementation on Peri-menopause Symptoms, Cognition, Sleep, and Psychological Well-being
Enrollment
58 pts
Location
United Kingdom
Sponsor
Northumbria University
View Trial →
NCT07427459
Recruiting
Amygdala Insula Retraining in the Management of Perimenopause Symptoms
Enrollment
160 pts
Location
United States
Sponsor
Chronic Conditions Research Fu...
View Trial →
NCT07242430
Recruiting
12-week Multi-vitamin/Mineral Supplementation on Peri-menopause Symptoms, Cognition, Sleep, and Psychological Well-being.
Enrollment
58 pts
Location
United Kingdom
Sponsor
Northumbria University
View Trial →
NCT07599930
Recruiting
Impact of a Novel Functional Snack on Perimenopausal Symptoms and Well-being
Enrollment
20 pts
Location
United Kingdom
Sponsor
King's College London
View Trial →

Related Conditions

perimenopausal women (2) perimenopause climacteric syndrome (2) menopausal complaints (1) perimenopause related depression (1) mood (1) sleep (1) quality of life (1) gut microbiota (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology